annual cash & cash equivalents:
$171.70M-$35.32M(-17.06%)Summary
- As of today (May 29, 2025), STE annual cash & cash equivalents is $171.70 million, with the most recent change of -$35.32 million (-17.06%) on March 31, 2025.
- During the last 3 years, STE annual cash & cash equivalents has fallen by -$176.62 million (-50.71%).
- STE annual cash & cash equivalents is now -50.71% below its all-time high of $348.32 million, reached on March 1, 2022.
Performance
STE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$171.70M+$16.52M(+10.65%)Summary
- As of today (May 29, 2025), STE quarterly cash & cash equivalents is $171.70 million, with the most recent change of +$16.52 million (+10.65%) on March 31, 2025.
- Over the past year, STE quarterly cash & cash equivalents has dropped by -$35.32 million (-17.06%).
- STE quarterly cash & cash equivalents is now -67.89% below its all-time high of $534.77 million, reached on June 30, 2021.
Performance
STE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -17.1% |
| 3 y3 years | -50.7% | -50.7% |
| 5 y5 years | -46.3% | -46.3% |
STE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.7% | at low | -50.7% | +10.7% |
| 5 y | 5-year | -50.7% | at low | -67.9% | +10.7% |
| alltime | all time | -50.7% | >+9999.0% | -67.9% | >+9999.0% |
STE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $171.70M(-17.1%) | $171.70M(+10.6%) |
| Dec 2024 | - | $155.18M(-9.9%) |
| Sep 2024 | - | $172.19M(-13.2%) |
| Jun 2024 | - | $198.33M(-4.2%) |
| Mar 2024 | $207.02M(-0.6%) | $207.02M(+5.8%) |
| Dec 2023 | - | $195.59M(-8.5%) |
| Sep 2023 | - | $213.76M(+2.5%) |
| Jun 2023 | - | $208.61M(+0.1%) |
| Mar 2023 | $208.36M(-40.2%) | $208.36M(-19.7%) |
| Dec 2022 | - | $259.37M(+0.4%) |
| Sep 2022 | - | $258.26M(-18.4%) |
| Jun 2022 | - | $316.33M(-9.2%) |
| Mar 2022 | - | $348.32M(-3.0%) |
| Mar 2022 | $348.32M(+57.9%) | - |
| Dec 2021 | - | $359.09M(-6.4%) |
| Sep 2021 | - | $383.49M(-28.3%) |
| Jun 2021 | - | $534.77M(+142.5%) |
| Mar 2021 | $220.53M(-31.0%) | $220.53M(-12.7%) |
| Dec 2020 | - | $252.50M(-19.1%) |
| Sep 2020 | - | $312.03M(+22.1%) |
| Jun 2020 | - | $255.63M(-20.0%) |
| Mar 2020 | $319.58M(+44.8%) | $319.58M(+60.4%) |
| Dec 2019 | - | $199.23M(-11.7%) |
| Sep 2019 | - | $225.54M(-5.3%) |
| Jun 2019 | - | $238.07M(+7.9%) |
| Mar 2019 | $220.63M(+9.5%) | $220.63M(-1.9%) |
| Dec 2018 | - | $224.91M(+7.1%) |
| Sep 2018 | - | $209.92M(-3.9%) |
| Jun 2018 | - | $218.52M(+8.4%) |
| Mar 2018 | $201.53M(-28.8%) | $201.53M(-29.0%) |
| Dec 2017 | - | $283.84M(-4.0%) |
| Sep 2017 | - | $295.63M(+0.3%) |
| Jun 2017 | - | $294.84M(+4.2%) |
| Mar 2017 | $282.92M(+13.7%) | $282.92M(+6.8%) |
| Dec 2016 | - | $264.86M(+4.1%) |
| Sep 2016 | - | $254.35M(+4.9%) |
| Jun 2016 | - | $242.42M(-2.6%) |
| Mar 2016 | $248.84M(+48.4%) | $248.84M(+7.6%) |
| Dec 2015 | - | $231.36M(+42.7%) |
| Sep 2015 | - | $162.19M(-17.3%) |
| Jun 2015 | - | $196.19M(+17.0%) |
| Mar 2015 | $167.69M(+9.7%) | $167.69M(+16.0%) |
| Dec 2014 | - | $144.51M(-2.0%) |
| Sep 2014 | - | $147.41M(-6.7%) |
| Jun 2014 | - | $157.94M(+3.4%) |
| Mar 2014 | $152.80M(+7.6%) | $152.80M(-2.9%) |
| Dec 2013 | - | $157.34M(-3.9%) |
| Sep 2013 | - | $163.79M(-1.2%) |
| Jun 2013 | - | $165.84M(+16.8%) |
| Mar 2013 | $142.01M(-5.8%) | $142.01M(-8.9%) |
| Dec 2012 | - | $155.89M(-0.5%) |
| Sep 2012 | - | $156.61M(-16.1%) |
| Jun 2012 | - | $186.73M(+23.8%) |
| Mar 2012 | $150.82M(-21.9%) | $150.82M(+4.9%) |
| Dec 2011 | - | $143.79M(+7.2%) |
| Sep 2011 | - | $134.11M(-14.1%) |
| Jun 2011 | - | $156.12M(-19.1%) |
| Mar 2011 | $193.02M(-10.2%) | $193.02M(+0.4%) |
| Dec 2010 | - | $192.29M(-11.6%) |
| Sep 2010 | - | $217.40M(-3.8%) |
| Jun 2010 | - | $226.07M(+5.2%) |
| Mar 2010 | $214.97M(+39.4%) | $214.97M(-19.0%) |
| Dec 2009 | - | $265.42M(+18.6%) |
| Sep 2009 | - | $223.76M(+27.1%) |
| Jun 2009 | - | $176.07M(+14.2%) |
| Mar 2009 | $154.18M | $154.18M(+45.4%) |
| Dec 2008 | - | $106.05M(-33.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $160.22M(+226.7%) |
| Jun 2008 | - | $49.04M(-5.5%) |
| Mar 2008 | $51.87M(-0.8%) | $51.87M(-6.4%) |
| Dec 2007 | - | $55.39M(-10.0%) |
| Sep 2007 | - | $61.56M(+6.2%) |
| Jun 2007 | - | $57.95M(+10.8%) |
| Mar 2007 | $52.30M(-28.1%) | $52.30M(+34.1%) |
| Dec 2006 | - | $39.01M(-13.1%) |
| Sep 2006 | - | $44.91M(-43.6%) |
| Jun 2006 | - | $79.56M(+9.4%) |
| Mar 2006 | $72.73M(+177.8%) | $72.73M(+62.9%) |
| Dec 2005 | - | $44.65M(-3.7%) |
| Sep 2005 | - | $46.38M(+23.8%) |
| Jun 2005 | - | $37.45M(+43.1%) |
| Mar 2005 | $26.18M(-67.4%) | $26.18M(-57.9%) |
| Dec 2004 | - | $62.20M(+89.7%) |
| Sep 2004 | - | $32.78M(-59.0%) |
| Jun 2004 | - | $79.93M(-0.6%) |
| Mar 2004 | $80.41M(+210.0%) | $80.41M(+107.0%) |
| Dec 2003 | - | $38.85M(+214.9%) |
| Sep 2003 | - | $12.34M(-34.7%) |
| Jun 2003 | - | $18.90M(-27.2%) |
| Mar 2003 | $25.94M(+108.8%) | $25.94M(+140.8%) |
| Dec 2002 | - | $10.78M(-32.5%) |
| Sep 2002 | - | $15.96M(+55.4%) |
| Jun 2002 | - | $10.27M(-17.3%) |
| Mar 2002 | $12.42M(-49.7%) | $12.42M(-27.7%) |
| Dec 2001 | - | $17.19M(+57.1%) |
| Sep 2001 | - | $10.94M(+51.8%) |
| Jun 2001 | - | $7.21M(-70.8%) |
| Mar 2001 | $24.71M(-30.3%) | $24.71M(+14.9%) |
| Dec 2000 | - | $21.50M(-26.0%) |
| Sep 2000 | - | $29.05M(+12.4%) |
| Jun 2000 | - | $25.85M(-27.1%) |
| Mar 2000 | $35.48M(+49.7%) | $35.48M(+24.0%) |
| Dec 1999 | - | $28.60M(-11.5%) |
| Sep 1999 | - | $32.30M(+83.5%) |
| Jun 1999 | - | $17.60M(-25.7%) |
| Mar 1999 | $23.70M(+38.0%) | $23.70M(+58.0%) |
| Dec 1998 | - | $15.00M(-40.2%) |
| Sep 1998 | - | $25.10M(+15.0%) |
| Jun 1998 | - | $21.82M(+27.1%) |
| Mar 1998 | $17.17M(-16.6%) | $17.17M(+3.4%) |
| Dec 1997 | - | $16.60M(-53.6%) |
| Sep 1997 | - | $35.81M(+46.6%) |
| Jun 1997 | - | $24.43M(+18.6%) |
| Mar 1997 | $20.60M(-85.4%) | $20.60M(-40.8%) |
| Dec 1996 | - | $34.80M(-38.6%) |
| Sep 1996 | - | $56.70M(-60.3%) |
| Jun 1996 | - | $142.80M(+1.4%) |
| Mar 1996 | $140.80M(+8700.0%) | $140.80M(>+9900.0%) |
| Dec 1995 | - | $900.00K(-55.0%) |
| Sep 1995 | - | $2.00M(+25.0%) |
| Jun 1995 | - | $1.60M(0.0%) |
| Mar 1995 | $1.60M(-40.7%) | $1.60M(-5.9%) |
| Dec 1994 | - | $1.70M(+21.4%) |
| Sep 1994 | - | $1.40M(-48.1%) |
| Jun 1994 | - | $2.70M(0.0%) |
| Mar 1994 | $2.70M(-86.4%) | $2.70M(-86.6%) |
| Dec 1993 | - | $20.10M(0.0%) |
| Sep 1993 | - | $20.10M(-2.9%) |
| Jun 1993 | - | $20.70M(+4.0%) |
| Mar 1993 | $19.90M(+1890.0%) | $19.90M(+64.5%) |
| Dec 1992 | - | $12.10M(+3.4%) |
| Sep 1992 | - | $11.70M(-14.0%) |
| Jun 1992 | - | $13.60M(+1260.0%) |
| Mar 1992 | $1.00M(+233.3%) | $1.00M(+233.3%) |
| Mar 1991 | $300.00K | $300.00K |
FAQ
- What is STERIS annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for STERIS?
- What is STERIS annual cash & cash equivalents year-on-year change?
- What is STERIS quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for STERIS?
- What is STERIS quarterly cash & cash equivalents year-on-year change?
What is STERIS annual cash & cash equivalents?
The current annual cash & cash equivalents of STE is $171.70M
What is the all time high annual cash & cash equivalents for STERIS?
STERIS all-time high annual cash & cash equivalents is $348.32M
What is STERIS annual cash & cash equivalents year-on-year change?
Over the past year, STE annual cash & cash equivalents has changed by -$35.32M (-17.06%)
What is STERIS quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of STE is $171.70M
What is the all time high quarterly cash & cash equivalents for STERIS?
STERIS all-time high quarterly cash & cash equivalents is $534.77M
What is STERIS quarterly cash & cash equivalents year-on-year change?
Over the past year, STE quarterly cash & cash equivalents has changed by -$35.32M (-17.06%)